The Alzheimer’s therapeutics and diagnostics market is expected to progress at a CAGR of 7.78% during the years 2019-2027.
Introduction to market
The market is driven by the rise in the number of Alzheimer’s cases and the growing demand for personalized drugs and affordable diagnostics tests. However, the stringent regulations for the development of drugs and clinical trials are hindering the growth of the ... Read more